Primary Record
Valrubicin
- In stock
- 3,868 g
- Purity
- 99.6 %
- CAS
- 56124-62-0
Compound Identifiers & Properties
- CAS
- 56124-62-0
- PubChem CID
- 454216
- SMILES
- CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O
- Canonical SMILES
- CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O
Names & Synonyms
- Valrubicin
- Valstar
- Valtaxin
- 56124-62-0
- Valrubicina
- Valrubicine
- Valrubicinum
- Antibiotic AD 32
- AD-32
- Valrubicin [USAN]
- Valstar Preservative Free
- Valstar (TN)
- Antibiotic AD-32
- Valrubicin (Standard)
- AD 32
- Valrubicin (AD-32)
- RefChem:57091
- VALRUBICIN [MI]
- DTXSID9046497
- Valrubicin (USP/INN)
- AC1L9RHG
- VALRUBICIN [INN]
- VALRUBICIN [HSDB]
- NSC-246131
- VALRUBICIN [VANDF]
- UNII-2C6NUM6878
- Valrubicin [USAN:USP:INN]
- VALRUBICIN [MART.]
- AD32
- C34H36F3NO13
- 2C6NUM6878
- N-Trifluoroacetyladriamycin-14-valerate
- VALRUBICIN [USP-RS]
- VALRUBICIN [WHO-DD]
- SCHEMBL12824
- DTXCID7026497
- HSDB 7288
- Trifluoroacetyladriamycin-14-valerate
- ZOCKGBMQLCSHFP-KQRAQHLDSA-N
- orb1299667
- orb3024952
- Valrubicin Intravesical Solution
- CHEMBL1096885
- SCHEMBL29418969
- VALRUBICIN [ORANGE BOOK]
- N-Trifluoroacetyladriamycin 14-valerate
- AOB2165
- EX-A493
- L01DB09
- VALRUBICIN [USP IMPURITY]
- CHEBI:135876
- MFCD01939322
- N-Trifluoroacetyldoxorubicin 14-valerate
- NSC246131
- GLXC-04256
- VALRUBICIN [USP MONOGRAPH]
- NSC 246131
- Adriamycin, trifluoroacetyl-, 14-valerate
- Tox21_112257
- BDBM50248236
- CID454216
- EBC-27441
- HY-13772R
- ZINC49783788
- AKOS027327568
- ACN-036870
- AT20560
- AV28661
- C34-H36-F3-N-O13
- CID:454216
- CS-2929
- DB00385
- NCGC00164738-01
- NCGC00390545-01
- BS-17624
- HY-13772
- J86.660A
- SID:134223399
- CAS-56124-62-0
- B3447
- NS00072615
- D02697
- Z-3187
- 124V620
- A830920
- C016163
- EN300-19806784
- Q7912593
- BRD-K72951360-001-01-4
- 2-oxo-2-((2S,4S)-2,5,12-trihydroxy-4-(((2R,4S,5S,6S)-5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl pentanoate
- B0084-182305
- (2S-cis)-Pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphth acenyl)-2-oxoethyl ester
- (5R)-3-(3-FLUORO-4-IODOPHENYL)-5-HYDROXYMETHYLOXAZOLIDIN-2-ONE
- [2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate
- [2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydropyran-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate
- 2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-{[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetamido)oxan-2-yl]oxy}-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
- (2-oxo-2-((2S,4S)-2,5,12-trihydroxy-4-((2R,4S,5S,6S)-5-hydroxy-6-methyl-4-((2,2,2-trifluoroacetyl)amino)oxan-2-yl)oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl)ethyl) pentanoate
- (2S-CIS)-2-(1,2,3,4,6,11-HEXAHYDRO-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-((2,3,6-TRIDEOXY-3-((TRIFLUOROACETYL)AMINO)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-2-NAPHTHACENYL)-2-OXOETHYL PENTANOATE
- (2S-cis)-2-(1,2,3,4,6,11-Hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl pentanoate
- (2S-cis)-Pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-.alpha.-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl ester
- (8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-alpha-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8(2)-valerate
- (8S,10S)-8-(Valeryloxymethylcarbonyl)-10-[(3-trifluoroacetylamino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- (8S,10S)-8-GLYCOLOYL-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-10-((2,3,6-TRIDEOXY-3-(2,2,2-TRIFLUOROACETAMIDO)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-5,12-NAPHTHACENEDIONE 8(SUP 2)-VALERATE
- (8S,10S)-8-Glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione 8(sup 2)-valerate
- 2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
- 2-Oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
- Pentanoic Acid 2-[(2S,4S)-1,2,3,4,6,11-Hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-alpha-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl Ester
- Pentanoic acid 2-oxo-2-[(8S)-1-methoxy-5,12-dioxo-6,8alpha,11-trihydroxy-10alpha-[[3-[(trifluoroacetyl)amino]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-5,7,8,9,10,12-hexahydronaphthacene-8-yl]ethyl ester
- Pentanoic acid, 2-((2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetylamino)-, alpha-L-lysohexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester
- Pentanoic acid, 2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester; Pentanoic acid, 2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester (9CI); Pentanoic acid, 2-[1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester, (2S-cis)-; AD 32; Antibiotic AD 32; N-Trifluoroacetyladriamycin 14-valerate; N-Trifluoroacetyldoxorubicin 14-valerate; NSC 246131; Trifluoroacetyladriamycin 14-valerate; Valrubicin; Valstar
- Pentanoic acid, 2-[1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester, (2S-cis)-